Login

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q3 FY2020
As of Sep 30, 2020
Q2 FY2020
As of Jun 30, 2020
Q1 FY2020
As of Mar 31, 2020
Q4 FY2019
As of Dec 31, 2019
Q3 FY2019
As of Sep 30, 2019
Q2 FY2019
As of Jun 30, 2019
Q1 FY2019
As of Mar 31, 2019
Q4 FY2018
As of Dec 31, 2018
Q3 FY2018
As of Sep 30, 2018
Q2 FY2018
As of Jun 30, 2018
Q1 FY2018
As of Mar 31, 2018
Q4 FY2017
As of Dec 31, 2017
Q3 FY2017
As of Sep 30, 2017
Q2 FY2017
As of Jun 30, 2017
Q1 FY2017
As of Mar 31, 2017
Q4 FY2016
As of Dec 31, 2016
Q3 FY2016
As of Sep 30, 2016
Q2 FY2016
As of Jun 30, 2016
Q1 FY2016
As of Mar 31, 2016
Q4 FY2015
As of Dec 31, 2015
ASSETS
Current assets:
Cash and cash equivalents
Accounts receivables, net of allowance of $1,473 and $448, respectively
Derivative instruments
Prepaid expenses and other current assets
Total current assets
Property and equipment:
Unproved
Proved
Total oil and natural gas properties
Less: accumulated depreciation, depletion, amortization and impairment
Oil and natural gas properties, full cost method of accounting, net
Other property and equipment, net
Total property and equipment, net
Right-of-use assets
Other assets
Total other assets
Total assets
LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS' EQUITY (DEFICIT)
Current liabilities:
Current portion of long-term debt
Debtor in-possession facility
Accounts payable
Accrued liabilities and other
Revenue payable
Dividends payable
Derivative instruments
Asset retirement obligations
Term loan - Heartland, net of discount
Total current liabilities
Other long-term liabilities
Asset retirement obligations
Long-term debt
Long-term derivative instruments and other non-current liabilities
Long-term deferred revenue liabilities
Derivative instruments
Long-term lease liabilities
Long-term deferred revenue and other liabilities
Total liabilities not subject to compromise
Liabilities subject to compromise
Total liabilities
Stockholders’ equity (deficit):
Series B Preferred stock, $0.0001 par value; stated value of $1,000; 20,000 shares authorized; 16,828 shares issued and outstanding at December 31, 2016, with a liquidation preference of $20,627 at December 31, 2016
Series B Preferred Stock
Common stock, $0.0001 par value per share; 150,000,000 shares authorized 95,097,919 and 91,584,460 issued and outstanding as of September 30, 2020 and December 31, 2019, respectively, of which 253,598 shares are being held in treasury stock
Additional paid-in capital
Treasury stock, 253,598 shares at cost
Accumulated deficit
Series A Preferred Stock
Series B Preferred Stock
Total stockholders’ equity (deficit)
Total liabilities, mezzanine equity and stockholders’ equity (deficit)
Mezzanine equity:
Series C-1 Preferred Stock
Series C-2 Preferred Stock
Series D Preferred Stock
Series E Preferred Stock
Series F Preferred Stock
Total mezzanine equity:

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support